methylphenobarbital inn also known mephobarbital usan jan mephobarbitone ban marketed brand names mebaral mephyltaletten phemiton prominal drug barbiturate derivative used primarily also sedative anxiolytic nmethylated analogue phenobarbital similar indications therapeutic value tolerability company stated letter website fdas unapproved drugs initiative fda longer willing allow drug grandfathered new drug application would needed submitted gain marketing approval would taken estimated five years time patients would required change therapies case last available tablets bore expiration date march drug longer available us supplies depleted symptoms overdose mephobarbital include confusion decrease loss reflexes somnolence fever irritability hypothermia poor judgment shortness breath slowtroubled breathing slow heartbeat slurred speech staggering trouble sleeping unusual movements eyes weakness httpsenwikipediaorgwikimethylphenobarbital